A Study of LY3041658 in Adults With Hidradenitis Suppurativa
A Study of LY3041658 in Adults With Hidradenitis Suppurativa
The reason for this study is to see if the study drug LY3041658 is effective in participants with moderate-to-severe hidradenitis suppurativa (HS).
Study Type: Interventional (Clinical Trial)
Estimated Enrollment: 52 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3041658 in Adults With Moderate-to-Severe Hidradenitis Suppurativa
Actual Study Start Date: August 26, 2020
Estimated Primary Completion Date: April 7, 2022
Estimated Study Completion Date: December 7, 2022
Arms:
- Experimental: LY3041658
- Placebo Comparator: Placebo
| Category | Value |
|---|---|
| Study type(s) | Interventional |
| Estimated enrolment | 52 |
| Actual Study start date | 26 August 2020 |
| Estimated Study Completion Date | 07 December 2022 |